Press Releases
BVIZ Vice President from Regensburg reelected
(No. 207) The CEO of BioPark Regensburg GmbH Dr. Thomas Diefenthal was elected as vice president for a further two years at the 53rd general meeting of the Federal Association of German Innovation, Technology and Startup Centers. The general meeting took place during the 30 year anniversary celebration of the association in Berlin.
read on
BioPark Regensburg gets silver again
(No. 206) The Cluster Management at BioRegion Regensburg has once again undergone an audit by the "European Cluster Excellence Initiative” and received the second highest award - the silver label certificate again.
read on
RCI Regensburg – Top-notch research from East Bavaria
(No. 205) The Regensburg Center for Interventional Immunology (RCI) is being accommodated at the BioPark until the completion of the new research building. Here the foundations for the development of new immunotherapies will be researched, to make therapeutic interventions for cancer, infectious diseases, autoimmune diseases as well as organ and stem cells transplants possible.
read on
New HTS Platform for Personalized Tumor Therapy
(No. 204) The Division of Personalized Tumor Therapy of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, based at the BioPark Regensburg, has founded a new working group “High-Throughput Drug and Target Discovery”. Its goal is to generate patient-derived preclinical in-vitro models for a multitude of cancer types and to subsequently use these in high-throughput drug and target screening campaigns for personalized tumor therapy.
read on
Opening Celebration for the New Construction in Marktredwitz
(No. 203) The new building for the two companies from the Bioregion Regensburg Cfm Oskar Tropitzsch GmbH and Iris Biotech GmbH was inaugurated with an opening ceremony in Marktredwitz. This family enterprise in its 7th generation founded in 1788 celebrated its 230th anniversary here with the motto “from alchemy to life sciences”.
read onARCHIVE
